Genetic Variations of Melatonin Receptor Type 1A are Associated with the Clinicopathologic Development of Urothelial Cell Carcinoma

Melatonin counteracts tumor occurrence and tumor cell progression in several cancer types in vitro and in vivo. It acts predominantly through its melatonin receptor type 1A (MTNR1A), and genetic variations of MTNR1A affect the susceptibility several diseases and cancer. The purpose of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yung-Wei, Wang, Shian-Shiang, Wen, Yu-Ching, Tung, Min-Che, Lee, Liang-Ming, Yang, Shun-Fa, Chien, Ming-Hsien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666544/
https://www.ncbi.nlm.nih.gov/pubmed/29104467
http://dx.doi.org/10.7150/ijms.20629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666544/
https://www.ncbi.nlm.nih.gov/pubmed/29104467
http://dx.doi.org/10.7150/ijms.20629

Ejemplares similares